The Global Hematology Diagnostics Market Size is predicted to reach USD 12.3 Billion by 2030 from USD 7.5 Billion in 2021, at a CAGR of 5.8% between 2022 and 2030, as per the Acumen Research and Consulting
In recent years, technical improvements and the introduction of new product kinds have been the key factors driving the worldwide hematology diagnostics market size. The growing emphasis on the effective diagnosis of rising incidences of blood disorders in both developing and developed nations is fueling global expansion in the hematology diagnostics market. Growing health concerns, an increasing number of diseases, and continuous innovations in wound care, as well as various benefits provided by hematology diagnostics such as less pain, optimal moisture level maintenance, and faster wound closure, have all contributed to global hematology diagnostics market growth.
Similarly, early disease detection and increased awareness are driving market expansion. However, the market may face obstacles such as limited awareness among the people in underdeveloped nations and expensive expenditures of highly automated devices.
Hematology Diagnostics Market Statistics
Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/935
Hematology Diagnostics Market Trends
According to recent studies, roughly 172,910 persons in the United States alone were diagnosed with blood malignancies such as lymphoma, leukemia, or myeloma in 2017. As a result, the global demand for advanced hematology analyzers is increasing fast. In addition, almost 1,290,773 people in the United States are either in remission or are living with myeloma, lymphoma, or leukemia. Increased awareness and knowledge of these disorders among healthcare professionals and patients have led to the use of sophisticated hematological diagnostic devices over the years. Aside from that, the increased acceptance of the aim of care-testing techniques, inventive advancements resulting in progressively exact outcomes and simple-to-use gadgets, and the simple accessibility of a wide range of tests are expected to drive the hematological diagnostics market.
Hematology Diagnostics Market Segmentation
The hematology diagnostics market can be segmented into several categories, including product, test type, and end-use.
Hematology Diagnostics Market Regional Overview
Geographically, the global hematology diagnostics market can be divided into Europe, Latin America, Asia Pacific, North America, and the MEA. According to a hematology diagnostics industry analysis, North America held the largest market share in 2021. This expansion can be attributed to key aspects such as an ever-increasing aging population, a perfect financing situation, innovative technology facilities, and the introduction of cutting-edge technologies for the POC test. Besides this, Asia-Pacific is predicted to expand at the fastest CAGR throughout the projection period. Growing per capita expenditure and increased adoption of modern diagnostic products, together with government initiatives to improve medical services, are expected to drive regional market development.
Hematology Diagnostics Market Players
Some of the major hematology diagnostics market companies are EKF Diagnostics, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Abbott Laboratories, HORIBA, Ltd., Boule Diagnostics, Drew Scientific, Sysmex Corporation, Ortho Clinical Diagnostics, and Bio-Rad Laboratories. To address the strong competition, these companies have used new product innovations, acquisitions and mergers, and collaborations.
Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/935
Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/935
Mr. Frank Wilson
Acumen Research and Consulting